Technical Analysis for ACST - Acasti Pharma, Inc.
|Grade||Last Price||% Change||$ Change|
ACST closed down 1.56 percent on Friday, January 13, 2017, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Trend Table & Recent Alerts
|See historical ACST trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 13||Calm After Storm||Range Contraction||0.00%|
|Jan 13||Narrow Range Bar||Range Contraction||0.00%|
|Jan 13||NR7||Range Contraction||0.00%|
|Jan 12||Calm After Storm||Range Contraction||-1.56%|
|Jan 12||Fell Below 50 DMA||Bearish||-1.56%|
|Jan 11||Expansion Pivot Buy Setup||Bullish Swing Setup||-8.70%|
|Jan 11||Stochastic Buy Signal||Bullish||-8.70%|
|Jan 11||Shooting Star Candlestick||Bearish||-8.70%|
|Jan 11||Wide Range Bar||Range Expansion||-8.70%|
|Jan 11||Volume Surge||Other||-8.70%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACST news...
|52 Week High||3.09|
|52 Week Low||1.11|
|200-Day Moving Average||1.45|
|50-Day Moving Average||1.31|
|20-Day Moving Average||1.27|
|10-Day Moving Average||1.28|
|Average True Range||0.15|
|Chandelier Exit (Long, 3 ATRs)||1.58|
|Chandelier Exit (Short, 3 ATRs)||1.56|
|Upper Bollinger Band||1.44|
|Lower Bollinger Band||1.1|
|Percent B (%b)||0.47|